Lymphocytes from multitransfused uremic patients have poor MLC reactivity

Area of Science:

• Immunology
• Nephrology

Background:

• Uremia, a condition associated with kidney failure, can impact immune function.
• Lymphocyte function is crucial for adaptive immunity and is often altered in chronic diseases.

Purpose of the Study:

• To investigate the mixed lymphocyte culture (MLC) reactivity of lymphocytes in uremic patients.
• To assess the influence of blood transfusion history and specific antibodies on immune responses.
• To determine the role of B cells and phagocytic cells in modulating MLC reactivity in uremia.

Main Methods:

• Comparing MLC reactivity between uremic patients and age-matched controls.
• Analyzing MLC responses based on blood transfusion units and presence of anti-HLA antibodies.
• Evaluating changes in MLC reactivity after selective removal or addition of B cells and phagocytic cells.
• Assessing phytohemagglutinin (PHA) reactivity in different patient subgroups.

Main Results:

• Lymphocytes from uremic patients showed significantly lower MLC reactivity compared to controls (P < 0.01).
• Lowest MLC responses were observed in multitransfused patients with multispecific anti-HLA antibodies.
• Removal of B cells or phagocytic cells significantly increased MLC reactivity in uremic responders (P < 0.05).
• PHA reactivity was significantly lower in multitransfused uremic patients compared to controls (P < 0.001).

Conclusions:

• Uremia impairs T-cell mediated MLC responses, with further reduction in multitransfused patients and those with anti-HLA antibodies.
• B cells and phagocytic cells may play a suppressive role in uremic T-cell responses.
• Phytohemagglutinin (PHA) responses are also diminished in heavily transfused uremic patients, suggesting broader immune dysfunction.